12/19/2019 Generic-Drug Approvals Soar, But Patients Still Go Without - WSJ

HEALTH

Generic-Drug Approvals Soar, But Patients

Still Go Without
Brand-name makers’ patent action limits release of the lower-price medicines, hindering cost-control
efforts

By Jared S. Hopkins
Nov. 19, 2019 4 20 pm ET

Record numbers of generic drugs for cancer, heart ailments and other conditions have received U.S.
approval in recent years, raising hopes that the new competition would reduce high drug costs. But
many of the lower-price medicines haven’t hit the market, a Wall Street Journal review found.

The result: Many patients are forced to take high-price medicines, and a widely touted remedy for
reining in drug costs has failed to live up to its promise.

...

TO READ THE FULL STORY

SUBSCRIBE SIGN IN

Continue reading your article with a WSJ

membership.

SUBSCRIBE NOW

https://www.wsj.com/articles/many-generic-drugs-havent-hit-market-hindering-cost-control-efforts-11574198448?mod=djem10point 1/2
12/19/2019 Generic-Drug Approvals Soar, But Patients Still Go Without - WSJ

SPONSORED OFFERS

MACY'S: FOOT LOCKER:

Extra 20% off + free shipping with Macy's Foot Locker coupons - 15% off $75 spend
promo code

TRAVELZOO: BLOOMINGDALE'S:
10% off bookings - Travelzoo promo code Get free delivery on mattresses worth
$1499 at Bloomingdale's

HERTZ: GROUPON:
40% off base rates with Hertz promo code Exclusive promo code:Extra 20% off

https://www.wsj.com/articles/many-generic-drugs-havent-hit-market-hindering-cost-control-efforts-11574198448?mod=djem10point 2/2